We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Julia Gillert Baker McKenzie

Results 1 to 5 of 38
Most popular |Most recent

UK government loses vote on future of medicines regulation

United Kingdom, European Union - July 18 2018 The UK House of Commons last night passed the “NC17” amendment to the government’s key Brexit legislation on medicines, essentially binding the UK to...

Els Janssens.

EMA issues new guidance for pharmaceutical companies in preparation for Brexit

United Kingdom, European Union - June 25 2018 On Tuesday 19 June, the European Medicines Agency (EMA) released an updated Brexit guidance for pharmaceutical companies; cautioning them to be...

Els Janssens.

The Future of the UK Life-Sciences Industry Post-Brexit

United Kingdom, European Union - June 19 2018 The future of the UK as a world-leading life sciences and pharmaceutical industry hub will be front and centre Tuesday June 19 during a meeting...

Els Janssens.

Key implications of the draft Brexit Withdrawal Agreement for pharma and medtech companies

United Kingdom, European Union - March 2 2018 A draft Withdrawal Agreement between the EU and the U.K. has been published by the European Commission (28022018), which puts the agreement on Phase...

Els Janssens.

EMEA Healthcare Industry Group - JanuaryFebruary 2018

United Kingdom, European Union - February 3 2018 The EU RoHS regime has been amended to remove what is known as the "hard stop" issue which would have otherwise limited certain resale and...

Els Janssens, Michelle L Bawn.